These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30952595)

  • 1. Peptides conjugated to 2-alkoxy-8-oxo-adenine as potential synthetic vaccines triggering TLR7.
    Gential GPP; Hogervorst TP; Tondini E; van de Graaff MJ; Overkleeft HS; Codée JDC; van der Marel GA; Ossendorp F; Filippov DV
    Bioorg Med Chem Lett; 2019 Jun; 29(11):1340-1344. PubMed ID: 30952595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gold Nanoparticles Coimmobilized with Small Molecule Toll-Like Receptor 7 Ligand and α-Mannose as Adjuvants.
    Shinchi H; Yamaguchi T; Moroishi T; Yuki M; Wakao M; Cottam HB; Hayashi T; Carson DA; Suda Y
    Bioconjug Chem; 2019 Nov; 30(11):2811-2821. PubMed ID: 31560198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and immunoregulatory activities of conjugates of a Toll-like receptor 7 inert ligand.
    Gao D; Liu Y; Li W; Zhong F; Zhang X; Diao Y; Gao N; Wang X; Jiang W; Jin G
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5792-5795. PubMed ID: 25453821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of the Immunostimulatory Activity of a TLR7 Ligand by Conjugation to Polysaccharides.
    Shinchi H; Crain B; Yao S; Chan M; Zhang SS; Ahmadiiveli A; Suda Y; Hayashi T; Cottam HB; Carson DA
    Bioconjug Chem; 2015 Aug; 26(8):1713-23. PubMed ID: 26193334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and immunological characterization of toll-like receptor 7 agonistic conjugates.
    Chan M; Hayashi T; Kuy CS; Gray CS; Wu CC; Corr M; Wrasidlo W; Cottam HB; Carson DA
    Bioconjug Chem; 2009 Jun; 20(6):1194-200. PubMed ID: 19445505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of plasmacytoid dendritic cells and B cells with two structurally different Toll-like receptor 7 agonists.
    Berggren O; Pucholt P; Amcoff C; Rönnblom L; Eloranta ML
    Scand J Immunol; 2020 Jun; 91(6):e12880. PubMed ID: 32219875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and immunostimulatory activity of 8-substituted amino 9-benzyladenines as potent Toll-like receptor 7 agonists.
    Jin G; Wu CC; Tawatao RI; Chan M; Carson DA; Cottam HB
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4559-63. PubMed ID: 16784848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplified Monopalmitoyl Toll-like Receptor 2 Ligand Mini-UPam for Self-Adjuvanting Neoantigen-Based Synthetic Cancer Vaccines.
    van den Ende TC; Heuts JMM; Gential GPP; Visser M; van de Graaff MJ; Ho NI; Jiskoot W; Valentijn ARPM; Meeuwenoord NJ; Overkleeft HS; Codée JDC; van der Burg SH; Verdegaal EME; van der Marel GA; Ossendorp F; Filippov DV
    Chembiochem; 2021 Apr; 22(7):1215-1222. PubMed ID: 33180981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glyco-Nanoadjuvants: Sugar Structures on Carriers of a Small Molecule TLR7 Ligand Affect Their Immunostimulatory Activities.
    Shinchi H; Yuki M; Yamauchi T; Niimura M; Wakao M; Cottam HB; Hayashi T; Carson DA; Moroishi T; Suda Y
    ACS Appl Bio Mater; 2021 Mar; 4(3):2732-2741. PubMed ID: 35014312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugation of a Small-Molecule TLR7 Agonist to Silica Nanoshells Enhances Adjuvant Activity.
    Huang CH; Mendez N; Echeagaray OH; Weeks J; Wang J; Vallez CN; Gude N; Trogler WC; Carson DA; Hayashi T; Kummel AC
    ACS Appl Mater Interfaces; 2019 Jul; 11(30):26637-26647. PubMed ID: 31276378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-(4-Amino-2-butyl-imidazoquinolyl)-norleucine: Toll-like receptor 7 and 8 agonist amino acid for self-adjuvanting peptide vaccine.
    Fujita Y; Hirai K; Nishida K; Taguchi H
    Amino Acids; 2016 May; 48(5):1319-29. PubMed ID: 26874701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugate of ibrutinib with a TLR7 agonist suppresses melanoma progression and enhances antitumor immunity.
    Ren S; Wang X; Jin G
    Int J Biol Sci; 2022; 18(1):166-179. PubMed ID: 34975325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of 8-oxoadenines with toll-like-receptor 7 and 8 activity.
    Bazin HG; Bess LS; Livesay MT; Li Y; Cybulski V; Miller SM; Johnson DA; Evans JT
    Bioorg Med Chem Lett; 2020 Mar; 30(6):126984. PubMed ID: 32001135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and immunostimulatory activity of substituted TLR7 agonists.
    Akinbobuyi B; Wang L; Upchurch KC; Byrd MR; Chang CA; Quintana JM; Petersen RE; Seifert ZJ; Boquin JR; Oh S; Kane RR
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4246-9. PubMed ID: 27476423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of 8-oxoadenine derivatives as potent Toll-like receptor 7 agonists with high water solubility.
    Nakamura T; Wada H; Kurebayashi H; McInally T; Bonnert R; Isobe Y
    Bioorg Med Chem Lett; 2013 Feb; 23(3):669-72. PubMed ID: 23265901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7.
    Hayashi T; Gray CS; Chan M; Tawatao RI; Ronacher L; McGargill MA; Datta SK; Carson DA; Corr M
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2764-9. PubMed ID: 19188597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Azidoalkoxy-7-hydro-8-oxoadenine derivatives as TLR7 agonists inducing dendritic cell maturation.
    Weterings JJ; Khan S; van der Heden van Noort GJ; Melief CJ; Overkleeft HS; van der Burg SH; Ossendorp F; van der Marel GA; Filippov DV
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2249-51. PubMed ID: 19299126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammation.
    Nencini F; Pratesi S; Petroni G; Filì L; Cardilicchia E; Casini A; Occhiato EG; Calosi L; Bani D; Romagnani S; Maggi E; Parronchi P; Vultaggio A
    Immunology; 2015 Aug; 145(4):570-82. PubMed ID: 25930741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TLR7 ligand 9-benzyl-2-butoxy-8-hydroxy adenine inhibits IL-17 response by eliciting IL-10 and IL-10-inducing cytokines.
    Vultaggio A; Nencini F; Pratesi S; Maggi L; Guarna A; Annunziato F; Romagnani S; Parronchi P; Maggi E
    J Immunol; 2011 Apr; 186(8):4707-15. PubMed ID: 21389257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
    Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA
    J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.